Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Rifampicin on Glucose, Lipid and Hormone Homeostasis
NCT01293422Phase 4Completed
- Sponsor
- University of Oulu
- Start
- Jan 2011
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rifampicin, sponsored by University of Oulu. Primary endpoint: Glucose levels during oral glucose tolerance test at 1 week. Started Jan 2011; status: completed.
02
Drugs
rifampicin
Beyond the preview
Go deeper on NCT01293422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01293422.